{"title":"The effect of two low-dose oral contraceptives and non-hormonal contraception on serum lipids and high-density lipoprotein cholesterol.","authors":"A Saure, J E Heikkinen, P Ylostalo","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 2","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"1984-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22005428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M A Abul-einn, F M Saleh, G H El-taba-kh, Y H Zaki
{"title":"Ultrasonography and missed threads of IUDs.","authors":"M A Abul-einn, F M Saleh, G H El-taba-kh, Y H Zaki","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"25-8"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22025523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I Sivin, P Holma, S Diaz, F Alvarez-sanchez, D N Robertson, J Stern
{"title":"Long-term experience with Norplant implants in international clinical trials.","authors":"I Sivin, P Holma, S Diaz, F Alvarez-sanchez, D N Robertson, J Stern","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Norplant subdermal implants containing levonorgestrel were used for contraception and compared with the Copper T, Model T Cu 200, during 42 months of use in an open study in Chile, the Dominican Republic, and Finland. Among 324 women enrolled for the implant regimen, there were no pregnancies in the 1st 2.5 years, and 2 by the end of 42 months. 1st segment net and gross cumulative pregnancy rates were 0.7 and 1.2/100 respectively, at 3.5 years. Cumulative pregnancy rates for the T Cu 200 group were 2.9, net and 3.5/100, gross at 42 months. More than 1/2 of the implant acceptors, 51.6/100 were continuing use at 3.5 years, somewhat above the continuation rate of the T Cu acceptors, 43.5/100, but not significantly so.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"53-62"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22025526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Influence of age on the clinical performance of IUD in nulliparous and parous women: an analysis of 1144 insertions.","authors":"S Kaivola, E Hirvonen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The influence of age on clinical performance of a new IUD, the Fincoid, was evaluated in 1144 nulliparous and parous women separately, with a follow-up of 12 months and with 11,859 woman-months of use. Of the individual terminations, the rates for pregnancies, expulsions, and removals for pain decreased with age, whereas removals for bleeding increased with age. This applies to both parous and nulliparous women. The IUD is not a 1st choice method of contraception for young nulliparous and parous women (under age 24). Patient materials should be analogous for age and parity to obtain comparable performances for different IUDs.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"7-10"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22024729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Scanning electron microscopy of the IUD tail.","authors":"U M Spornitz, S Makabe, E S Hafez, W A Van Os","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"29-45"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22025524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical trial of a long-acting injectable contraceptive: NET-EN.","authors":"C Chaudhuri, M Mukherjea","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Injectable progestogen, norethisterone enanthate (NET-EN, 200 mg/ml) was administered to 122 women at 2 month intervals for more than 1 year. Only a minority of women had consistently normal cycles. Most women experienced some menstrual irregularities: 57% of users experienced irregular bleeding, 32% developed amenorrhea, while only 11% showed regular cyclic bleeding. Important nonmenstrual side effects were weakness and abdominal pain. No appreciable changes in body weight and blood pressure were recorded.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"47-52"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22025525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prolactin level after prolonged lactation: contraceptive evaluation.","authors":"M Lotfy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A study was conducted to evaluate serum prolactin during lactation among 60 mothers with prolonged breastfeeding for 2 years. Patients were classified into 3 groups with 20 in each: lactating for less than 6 months, lactating for 6-12 months, and lactating for 12-24 months. There was hyperprolactinemia during lactation and serum prolactin levels decreased as lactation progressed. After long lactation (over a year), 10 of 20 women were amenorrheic and 10 were menstruating; 6 of the menstruating women were ovulating and 4 nonovulating. Prolonged lactation was found to be relatively successful for family spacing.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"63-6"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22025527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The influence of copper on the transport of microspheres through the human oviduct in vitro.","authors":"B Larsson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"67-9"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22024728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Canadian regulation of contraceptive devices.","authors":"M S Smith","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Widespread use and technical developments associated with oral contraceptives (OCs), IUDs, techniques involved with abortion, and laparoscopy have resulted in hazards which require governmental control. The objectives and regulatory aspects of contraceptive devices undertaken by the Bureau of Medical Devices is described. The development of quality standards, both voluntary and regulatory, and the importance of postmarket controls for contraceptive devices are recent developments designed to ensure improvement in the health of the Canadian public. New and developing contraceptive device technology may have profound effects on the health and wellbeing of the Canadian public. The challenge of ensuring the safety and efficacy of contraceptive devices must be better met by communication from those patients who are affected. Physician and other allied health professionals who interface with the patient must be sensitive to the concerns of the patients.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22024888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Corrosion and weight loss from copper wire in the Fincoid IUD in utero.","authors":"S Kaivola, E Hirvonen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A total of 190 Fincoid IUDs were removed after varying periods of use in utero. Of 84 wires removed after 4 years of use, the 1st 12 wires were SEM photographed. In 1 of these wires, which was fragmented, a SEM photograph revealed deep corrosion pits. In the 11 unbroken wires, SEM photographs disclosed no clear pitting corrosion. Among 84 copper wires removed after 4 years of use, there were 4 fragmented ones. The risk of fragmentation after 4 years was thus 4.8%. Among the 106 copper wires removed for different reasons before the lapse of 4 years, there was not a single fragmented one. Annually, the mean daily release of copper ranged from 40.2 mcg to 43.3 mcg without any markedly higher initial release, 80% of the original weight still existing in the copper wires after 4 years in utero. The low incidence of pitting corrosion and fragmentation is most probably attributable to the higher positioning of the copper wire on the IUD. It is concluded that the effective life of the Fincoid IUD is more than 4 years.</p>","PeriodicalId":84493,"journal":{"name":"Contraceptive delivery systems","volume":"5 2","pages":"105-8"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22005431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}